Levy Jäger
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
Papers in
-
- Healthcare cost, quality, practices 2
-
- Cervical Cancer and HPV Research 3
- Co-authors
- Thomas Rosemann (11 shared papers)Stefan Markun (9 shared papers)Jakob M. Burgstaller (8 shared papers)Navdeep Tangri (2 shared papers)Avraham Karasik (2 shared papers)Manuel Botana (2 shared papers)Andreas Bollmann (2 shared papers)Marcus Thuresson (2 shared papers)
- Journals
- Nutrients (2 papers)JAMA Network Open (2 papers)PLoS ONE (2 papers)Swiss Medical Weekly (2 papers)Vaccines (1 paper)
- Partner nations
- SwitzerlandUnited KingdomGermany
In The Last Decade
Levy Jäger
16 papers receiving 371 citations
Levy Jäger's Hit Papers
Peers
Comparison fields: 5 of 77
- Nephrology 110
- Applied Microbiology and Biotechnology 8
- Biological Psychiatry 7
- Geriatrics and Gerontology 7
- Endocrinology, Diabetes and Metabolism 34
Countries citing papers authored by Levy Jäger
This map shows the geographic impact of Levy Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levy Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levy Jäger more than expected).
Fields of papers citing papers by Levy Jäger
This network shows the impact of papers produced by Levy Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levy Jäger. The network helps show where Levy Jäger may publish in the future.
Co-authors
The 25 scholars most cited alongside Levy Jäger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study Hit paper breakdown → | 2022 | 208 |
| 2 | 2021 | 71 | |
| 3 | 2020 | 21 | |
| 4 | 2018 | 13 | |
| 5 | 2022 | 9 | |
| 6 | 2023 | 9 | |
| 7 | 2024 | 8 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2023 | 0 | |
| 18 | 2024 | 0 |
About Levy Jäger
Levy Jäger is a scholar working on General Health Professions, Epidemiology, Nephrology, Neurology and Rheumatology, having authored 18 papers that have together received 377 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (3 papers), Folate and B Vitamins Research (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Alcoholism and Thiamine Deficiency (2 papers), Healthcare cost, quality, practices (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Nephrology (110 citations), Applied Microbiology and Biotechnology (8 citations), Biological Psychiatry (7 citations), Geriatrics and Gerontology (7 citations) and Endocrinology, Diabetes and Metabolism (34 citations). Levy Jäger has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include Thomas Rosemann, Stefan Markun, Jakob M. Burgstaller, Navdeep Tangri, Avraham Karasik, Manuel Botana, Andreas Bollmann, Marcus Thuresson, Tiago Taveira‐Gomes and Marc Vervloet. Their work appears in journals such as Nutrients, JAMA Network Open, PLoS ONE, Swiss Medical Weekly and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.